Peptone

Private

LondonHealthcare & Life Scienceshttps://peptone.io/

Last Round

Series A

Jun 9, 2022

Total Funding Raised

$42.5M

Company Overview

Peptone is a biopharmaceutical company that specializes in the discovery of innovative therapeutics targeting intrinsically disordered proteins through advanced biophysics, supercomputing, and machine learning.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

computational drug discoveryintrinsically disordered proteinsIDPprotein dynamicsundruggable targetsAI drug discoveryin silico drug designHDX-MShydrogen-deuterium exchangesmall molecule therapeuticsprotein engineeringmolecular dynamics simulationbiophysicsdrug discovery platformADOPT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Peptone Comps

Public and private peers based on sector, stage, and business model.

Peptone comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Peptone Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Jun 9, 2022
Seed	Jan 8, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Kamil Tamiola

CEO and Founder

Founding Team

Carlo Fisicaro

Chief Technology Officer

Executive Team

Kevin Sprott

Chief Operating Officer

Executive Team

Peptone Investors

Notable investors and investment history

Peptone investors
Investor	Rounds
dRx Capital	Seed, Series A
F-Prime Capital	Series A
Hoxton Ventures	Series A, Seed
Walden Catalyst	Series A
Bessemer Venture Partners	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 9, 2025
Kevin Tyler Sprott appointed as COO.

View all signals

Peptone Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Peptone Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Peptone's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon

Employee Range46

Year Founded2016

Last FundingJun 9, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.